FACT II Acquisition Corp. (NASDAQ:FACTU) announced the pricing of its $175 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “FACTU”, Tuesday, November 26, 2024.
The new SPAC intends to conduct a broad search and combine with a target company that has demonstrated operating expertise over the past two years with a focus on growing revenues.
FACT II’s sponsor team is led by Chief Executive Officer and Director Adam Gishen and Chief Financial Officer Min Lee. Robert Rackind, Nell Cady-Kruse, James Rallo, and Hella Alashkar will serve on its Board of Directors.
Total SPAC deal count for 2024 year-to-date is now 50. This offering is expected to close on Wednesday, November 27, 2024.
Cohen & Company Capital Markets, a division of J.V.B. Financial Group, LLC, is acting as lead book-running manager, and Seaport Global Securities is acting as joint book runner. Paul Hastings LLP is serving as Issuer’s Counsel with Greenberg Traurig LLP serving as Underwriter’s Counsel. WithumSmith+Brown, PC serves as auditor. Odyssey Transfer and Trust Company is acting as trustee.
At the SPAC of Dawn While futures indicate the Santa rally may be retreating back to the North Pole, de-SPACs have nonetheless notched a solid week and SPACs still in other points in their processes still have plenty of business left on their plate. Three SPACs are asking shareholders for extensions today while two more...
SPACInsider 2024 Awards 2024 was clearly a rebuilding year for SPACs and the pace didn’t really gather momentum until June. But in typical SPAC fashion, once the market catches fire, it builds very, very quickly. With that being said, there are some noteworthy standouts this year that are worth highlighting. As such, this is the...
At the SPAC of Dawn (UPDATED) It was a slow start to the day after the Christmas holiday, especially because the SEC was “experiencing technical difficulties” this morning. That makes for a slow news day. Other than that, we hope everyone had a great holiday and is easing back into the work flow. Deals and...
Aimei Health Technology II Co., Ltd (NASDAQ:AHJKU) has filed for a $60 million SPAC ostensibly to pair up with a small cap biotech or medical device target, but its team’s experience both in SPACs and beyond suggest the vehicle will be open to a broad set of potential targets. It is the first SPAC to...
At the SPAC of Dawn The markets got to open one stocking early yesterday, but it was mostly coal as it showed durable goods orders had declined by more than twice as much as expected to -1.1% in November. It wasn’t all signs of naughtiness, however. Amid the numbers that came public one day earlier...